Log In
Print this Print this

naluzotan (PRX00023)

  Manage Alerts
Collapse Summary General Information
Company Upsher-Smith Laboratories Inc.
DescriptionSerotonin (5-HT1A) receptor agonist
Molecular Target Serotonin (5-HT1A) receptor
Mechanism of ActionSerotonin (5-HT1) receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationEpilepsy
Indication DetailsTreat epilepsy; Treat localization-related epilepsy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today